
To act as the strategic leader for regulatory affairs, driving global and India regulatory strategies for NCE development through the 505(b)(2) pathway.
To oversee end-to-end regulatory submissions, ensure compliance with CDSCO and international agencies, and serve as the primary liaison with health authorities.
To collaborate closely with R&D, clinical, and commercial teams to integrate regulatory requirements into development plans while mentoring a high-performing regulatory team.
To lead regulatory strategy and execution for New Chemical Entities (NCEs), focusing on 505(b)(2) submissions for India and global markets. This role involves end-to-end regulatory planning, liaison with local and international health authorities (CDSCO, USFDA, EMA, etc.), and ensuring compliance throughout the product lifecycle. The position also requires strong collaboration with cross-functional teams and oversight of regulatory intelligence to support business objectives.
Regulatory Strategy & Submissions
Global & Local Liaison
Compliance & Governance
Cross-functional Collaboration
Regulatory Intelligence
Leadership & Team Development
M. Pharm
Amneal is an equal opportunity employer. We do not discriminate based on caste, religion, gender, disability, or any other legally protected status. We believe in fostering a workplace that values diversity and inclusion.

Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership development and employee well-being programs – all so we can deliver even more value. We are Amneal and We make healthy possible.
Content is for informational purposes only and 3rd party content does not reflect Amneal’s opinions.
Amneal has the right to remove comments that violate another’s copyright or intellectual property, mention an Amneal product, use profanity or are defamatory, promote and solicit for third-party sites, initiatives, or products, or are factually inaccurate or misleading or spam.
Amneal recommends that you consult with your healthcare provider regarding personal health matters. To report a product complaint or adverse event related to an Amneal product, contact Drug Safety at 877-835-5472, option 3 or drugsafety@amneal.com. If you are currently experiencing a life-threatening event, please immediately contact 911.